Sexual and Urinary Function Improvement for Cancer Survivors

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18+
SponsorNYU Langone Health

About this trial

The purpose of this study is to test the efficacy of SUFICS-PACT to identify and treat sexual and urinary dysfunction in prostate cancer survivors at NYC H+ H/Bellevue, the oldest public hospital in the US. This study will evaluate the implementation of an adapted sexual and urinary function collaborative care model at NYC Health+Hospitals/Bellevue. The study will test the efficacy of this collaborative care model through a randomized controlled trial in the adult primary care clinic; the intervention arm will receive collaborative treatment consisting of a care manager who has specialty training in mental health and psychosexual counseling, a primary care nurse practitioner who leads symptom management, primary care physicians who supervise the team, and a team specialty consult liaison.

Eligibility criteria

Qualifiers

At least 18 years old

Have a diagnosis of prostate cancer

Have sought care/treatment for prostate cancer

Disqualifiers

Patients under 18 years old

Patients who have not sought care/treatment for prostate cancer

Patients who are categorized as "vulnerable subjects," such as minors or incarcerated individuals.

Trial design

Treatments tested in this trial

  • SUFICS-PACT

Treatment groups

200 Participants
are divided into 2 treatment groups

Sponsors and collaborators